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Background: Immunoglobulin (IG) complementarity determining region (CDR) includes
VH CDR1, VH CDR2, VH CDR3, VL CDR1, VL CDR2 and VL CDR3. Of these, VH CDR3 plays
a dominant role in recognizing and binding antigens. Three major mechanisms are
involved in the formation of the VH repertoire: germline gene rearrangement, junctional
diversity and somatic hypermutation. Features of the generation mechanisms of
VH repertoire in humans and mice share similarities while VH CDR3 amino acid
(AA) composition differs. Previous studies have mainly focused on germline gene
rearrangement and the composition and structure of the CDR3 AA in humans and
mice. However the number of AA changes due to somatic hypermutation and
analysis of the junctional mechanism have been ignored.
Methods: Here we analyzed 9,340 human and 6,657 murine unique productive
sequences of immunoglobulin (IG) variable heavy (VH) domains derived from IMGT/
LIGM-DB database to understand how VH CDR3 AA compositions significantly differed
between human and mouse. These sequences were identified and analyzed by IMGT/
HighV-QUEST (http://www.imgt.org), including gene usage, number of AA changes due
to somatic hypermutation, AA length distribution of VH CDR3, AA composition, and
junctional diversity.
Results: Analyses of human and murine IG repertoires showed significant differences.
A higher number of AA changes due to somatic hypermutation and more abundant
N-region addition were found in human compared to mouse, which might be an
important factor leading to differences in VH CDR3 amino acid composition.
Conclusions: These findings are a benchmark for understanding VH repertoires and
can be used to characterize the VH repertoire during immune responses. The study
will allow standardized comparison for high throughput results obtained by IMGT/
HighV-QUEST, the reference portal for NGS repertoire.
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Immunoglobulin (IG) protects against the invasion of pathogenic microorganisms and
is an important effector molecule in the immune response. IG is a tetramer composed
of two heavy (H) chains and two light (L) chains (Kappa or Lambda). The variable
domain at the N-terminal end of each chain is generated by the rearrangement of a
variable (V) gene, a diversity (D) gene (for the VH) and a joining (J) gene. The IG© 2014 Shi et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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respectively [1,2] (IMGT Repertoire in IMGT®, the international ImMunoGeneTics
information system® [3,4], http://www.imgt.org). In addition, somatic hypermutation
(SHM) contributes to the diversity of the IG V domain [5]. The third complementarity-
determining region of the IG heavy chain (VH CDR3) functions as the center of the
classical antigen-binding site and it often influences how the specificity and affinity of
the antibody is determined [6-9]. Due to its key role in antigen binding, the VH
CDR3 has become a target for the introduction of hypervariability in synthetic anti-
body libraries [10,11], which can be used for engineering therapeutic antibodies [12].
In the body, VH CDR3 is more diverse than any of the other five CDRs [13,14], which
is generated by deletion and insertion of random nucleotides (nts) during joining
(junctional diversity) [15].
Immunoinformatics tools have been developed for the detailed analysis of the V
domains taking into account the complex mechanism of their synthesis [4]. Thus
IMGT/V-QUEST [16-18] provides the identification of the closest V and J germline genes
involved in the rearrangement, analysis of the somatic mutations and AA changes,
and with the integrated IMGT/JunctionAnalysis [19,20], a detailed characterization of
the junction and identification of the D genes. The online version of IMGT/V-QUEST
analyses 1 to 50 sequences per run. A high throughput version, IMGT/HighV-QUEST
[17,21,22], analyzes up to 500,000 IG or T cell receptors (TR) sequences. High quality
results are based on the standardized concepts of IMGT-ONTOLOGY [23], that are
generated from the axioms of CLASSIFICATION (standardized nomenclature) [24],
DESCRIPTION (standardized labels) [25], NUMEROTATION (IMGT unique numbering
[26-28], IMGT Collier de Perles [29]). IMGT/HighV-QUEST results are identical to those
obtained by IMGT/V-QUEST online, except for the IMGT Collier de Perles.
Generally, human and mouse are considered as the most developed models for
the generation of IG diversity [30]. Previous studies have shown that human and
murine VH CDR3 repertoires share similarities, i.e., tyrosine, glycine and serine tend to
predominate in their amino acid (AA) composition [31,32] and the length distribution of
CDR3 is nearly normally distributed [32]. However, they significantly differ regarding
AA composition, including VH CDR3 of equal length [32]. Features of the generation
mechanisms of VH CDR3 repertoire in humans and mice share similarities while their
AA composition differs. Why AA composition of VH CDR3 differs between human
and mouse is unclear. Previous studies have focused on the germline gene rearrangement.
However, number of AA changes due to somatic mutations and junctional diversity have
been largely ignored. Comparing these mechanisms between human and mouse will
clarify the nature of the VH CDR3 repertoire. Moreover, to efficiently produce more
realistic synthetic antibody libraries, it is important to understand the rules and
restrictions that act upon the composition of the VH CDR3 region.
Over the past few years, large collections of sequences have been deposited in the
IMGT/LIGM-DB database [33,34]. From this database, 10,507 human sequences and 8,362
murine sequences were queried. However, such a large amount of data is a challenge for
the subsequent comparative analysis of human and mouse IG VHs. Recently, IMGT/
HighV-QUEST is widely applied in analysis of NGS data of IG or TR (T cell receptor)
repertoire. Based on IMGT/HighV-QUEST results, we identified and compared 9,340
human and 6,657 murine unique, productive and in-frame sequences of IG VH from
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mutations, CDR3 length distribution and AA composition, and junctional diversity.Results
The analyzed sequences were derived from different laboratories. Generally, different
laboratories measured different lengths according to their research imperatives. Therefore,
we only retained those sequences that contained a complete V region. Although sequences
were considered effective because that came from the IMGT/LIGM-DB, we still removed
some deemed invalid by IMGT/HighV-QUEST. After eliminating all redundant, ambiguous,
incomplete, or unproductive sequences from the sequences contained within the IMGT/
LIGM-DB, we identified 9,340 human and 6,657 murine unique productive Ig V-region
sequences.Germline gene usage
Both human and murine gene usages were shown in Additional file 1: Figure S1A-H. For
the human IGHV gene subgroup, our data covered 52 (52/71) IGHV genes. Of these,
IGHV1-69 (7.7%), IGHV5-51 (6.8%), IGHV4-34 (7.5%), IGHV3-30 (6.9%) and IGHV3-23
(7.7%) were more used, while IGHV5-78, IGHV1-45, IGHV4-28, IGHV3-43D and
IGHV3-NL1 were used less than 0.1%. In IGHD and IGHJ gene set, IGHD3-10 at 11.8%
and IGHJ4 at 44.1% were the most favored genes. For the murine IGHV gene subgroup,
our data covered 130 (130/130) IGHV genes. Surprisingly, the frequency of IGHV1-72 at
43.1% was significantly higher than any other genes. Similarly, in the IGHD gene set,
IGHD1-1 at 39.2% was predominately used. In the IGHJ gene family, IGHJ4 were in
highest usage at 41.8%. In human and murine sequences, sequences without the D
gene were 0.7% and 3.7%, respectively.Analysis of the number of AA changes due to somatic hypermutation
Numbers of V region AA changes were compared between human and murine sequences
(Figure 1A-B), but we excluded mutations at the CDR3 and FR4 because of their involve-
ment in the rearrangement process. As shown in Figure 1A, the numbers of sequences
decrease with increasing the numbers of AA changes in both human and mouse, but
sequences without AA changes were found more frequently in mouse than in human
(31.0% versus 12.3%). A higher sequence frequency occurred in mouse than in human
(70.6% versus 35.7%) when the number of AA changes ranged from 0 to 5. If the number
of AA changes ranged from 6 to 8, the human sequence frequency was roughly identical
to that of the murine sequence (14.4% and 13.6%, respectively). When the range of
the number of AA changes exceeded 9, then a higher sequence frequency occurred in
human than in mouse (49.9% versus 15.8%). Moreover, human sequences had higher
average numbers of AA changes in FR1, CDR1, FR2, CDR2 and FR3 compared to
murine sequences (each p < 0.001, ANOVA; Figure 1B).CDR3 length distribution and AA composition
Length distribution of VH CDR3
VH CDR3 length in human ranged from 4 to 36 according to the IMGT numbering and
it was wider than in mouse, which ranged from 4 to 28 (Additional file 1: Figure S2).
Figure 1 Number of amino acid (AA) changes of all human (n = 9340) and mouse (n = 6657) sequences
is shown. A Total number of AA changes in the V regions of VH domain. B The number of AA changes
observed in FR1, CDR1, FR2, CDR2, and FR3 of VH domain, with the mean ± SD. The p values were determined
using ANOVA. All statistically significant differences are indicated. * = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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in mouse (11.5 ± 1.9 AA residues). The most frequently occurring length in human
was 14 (11.7%) whereas mouse had three fewer AA residues at 11 (19.8%) (Additional
file 1: Figure S2).
Overall AA usage of VH CDR3
Overall AA usages of human and murine VH CDR3 are shown in Figure 2. The amino
acids most frequently used in human and mouse are tyrosine, alanine, aspartic acid,
arginine, glycine and serine. Significant differences in overall AA composition between
human and mouse exist (χ2 test, 19 degrees of freedom, p < 0.001). Obviously, the
usage frequency of tyrosine in mouse was higher than in human (24.4% versus 11.3%,
p < 0.00001%, χ2 test). Usage frequencies of lysine, glutamine, glutamic acid, histidine,
proline, serine, threonine, glycine, cysteine, leucine, valine and isoleucine in human was
higher than in mouse (each p < 0.00001%, χ2 test) and the murine model showed higher
utilization of arginine, alanine and phenylalanine compared to the human model (each
p < 0.00001%, χ2 test). Over-utilization of tyrosine led to a strong bias in the overall AA
composition of murine VH CDR3, while human VH CDR3 showed a more balanced
overall AA composition.
Overall AA usage of VH CDR3 at different positions
According to IMGT numbering, we identified all positions 105–117 of VH CDR3
sequences and calculated overall AA frequencies for all positions of CDR3 sequences
(Figure 3 shows 10 positions, but other positions are not shown). At the N-terminal of
VH CDR3, both human and murine sequences at position 105 frequently utilized
alanine (86.0% and 86.5%, respectively). At position 106, human sequences AA mainly
Figure 2 Average values of AA composition calculated for all human (n = 9340) and mouse (n = 6657)
VH CDR3 sequences in percent shows the difference from overall amino acid composition in human
and murine. The amino acids are arranged by relative hydrophobicity values as found in Kyte-Doolittle scale
[35]. The overall amino acid composition differed significantly between human and murine VH CDR3 ( χ2 test,
19 degrees of freedom, p < 0.001). Comparing the frequencies of individual amino acid residues, the definite
level of significance was better than *0.05%, **0.001%, or ***0.00001% using χ2 test and post-hoc analysis as
described by Collis et al. [36].
Shi et al. Theoretical Biology and Medical Modelling 2014, 11:30 Page 5 of 11
http://www.tbiomed.com/content/11/1/30utilized positively charged arginine (68.8%) and lysine (13.4%) and the arginine was
found in 81.9% of the murine sequences. At position 115 of the C-terminal of VH CDR3,
AA contained in human sequences were phenylalanine (49.7%), methionine (20.3%) and
leucine (11.0%), as did the three most frequent amino acids in murine sequences (64.8%,
21.6% and 3.9%, respectively). At position 116, both human and murine sequences
frequently utilized aspartic acid (84.2% and 76.6%, respectively). However, at position 117,
the usage of tyrosine in mouse sharply exceeded the human (80.6% versus 32.4%).Junctional diversity
We analyzed all clearly identified 9,340 human sequences and 6,657 murine unique IG
V-region sequences. The V-D-J junctional diversity results from the addition ofFigure 3 The frequency of individual amino acids at the specific ten positions for all human (n = 9340)
and mouse (n = 6657) VH CDR3 sequences is shown. The color menu for amino acids is according to IMGT
[37]. CDR3 positions are shown according to the IMGT unique numbering. A human. B mouse.
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nucleotides (N region) at the V→D (N1) and D→ J (N2) junctions (Figure 4A-B).
Sequences occurring in the P-region (P3'V + P5'D + P5'J) addition accounted for
26.8% and 31.2% of overall sequences in human and mouse, respectively. There was a
similar average number of nucleotides added in both human and murine P regions
(0.5 ± 0.7 and 0.5 ± 0.7, respectively). The occurrence rate of exonuclease trimming
was similar in human and mouse (99.9% and 99.4%, respectively). Sequences occurring in
the N-region (N1 +N2) addition accounted for 98.2% and 83.1% of overall sequences in
human and mouse, respectively. We found the average number of nucleotides added inFigure 4 The V-D-J junctional diversity created by P region, exonuclease trimming and N region addition
significantly contributes to a large VH CDR3 repertoire. A The numbers of N, P nucleotides added at the
V-D-J junctions and nucleotides deleted by exonuclease trimming are shown, with the mean ± SD. The p values
were determined using ANOVA. All statistically significant differences are indicated. * = p < 0.05, ** = p < 0.01,
*** = p < 0.001. B The numbers of N1, N2, P3'V, P5'D and P5'J nucleotides added at the V-D-J junctions and
nucleotides deleted at the 3'V, 5'D, 3'D and 5'J by exonuclease trimming are shown, with the mean ± SD. The
p values were determined using ANOVA. All statistically significant differences are indicated. * = p < 0.05,
** = p < 0.01, *** = p < 0.001.
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p < 0.001, ANOVA). For the average number of nucleotides lost due to exonuclease
trimming, we found it sharply greater in human than in mouse (18.8 ± 7.0 versus
12.4 ± 4.8, p < 0.001, ANOVA). Figures for total addition and trimming in each
domain are shown in Figure 4b and the numbers of nucleotides added in the N1
and N2 regions in human exceeded mouse (6.6 ± 4.3 versus 2.4 ± 2.2, 6.4 ± 4.6 versus
2.1 ± 1.8, respectively; each p < 0.001, ANOVA). The numbers of nucleotides
trimmed in the 3'V region of human and mouse were less than those in the other
three regions, but the number of nucleotides trimmed in each region was greater in
human than in mouse (each p <0.001, ANOVA).Discussion
Human and mouse are the best developed models for the generation of IG diversity.
However, due to limitations in the methodology, analysis of large data is difficult so
that their IG information is not fully mining. Recently, IMGT/HighV-QUEST has
been successfully applied in analysis of IG or TR repertoires. In the study, we used
IMGT/HighV-QUEST to make comparative analysis of the human and mouse IG
VHs from IMGT/LIGM-DB.
In the aspect of human and mouse germline genes, we noted significant preferential
usage of several genes, i.e., IGHJ4 for humans and IGHV1-72, IGHD1-1, and IGHJ4 for
mice. These IGHV genes are worth examining further.
Although presumably human and mouse must tolerate or eliminate similar classes of
antigens and/or similar ranges of antigenic epitopes, their difference in AA composition
of VH CDR3 was partly determined by the difference in junctional diversity and som-
atic hypermutation. The average number of nts added in the N region was sharply
greater in human than in mouse (13.0 ± 6.3 versus 4.4 ± 3.0) with a higher occurrence
rate of N-region addition than mouse (98.2% versus 83.1%). Hence, increased N-region
addition results in more frameshift mutations that encode more amino acids and
increase the diversity of human VH CDR3 by altering inserted positions and down-
stream codons. Thus, the AA composition of human VH CDR3 is more balanced. Scarce
N-region addition in mouse might lead to shorter length and narrower distribution of
VH CDR3. Moreover, fewer V region AA changes in human sequences occurred in
low mutation regions (ranging from 0 to 5) (35.7% versus 70.6%) but more happened
in high mutation regions (above 9) (49.9% versus 15.8%). Greater average numbers of
AA changes in FR1, CDR1, FR2, CDR2 and FR3 suggests that a higher level of somatic
mutation in human ensures immunoreaction to the diverse external environment.
Although analyses of human and murine IG repertoires showed significant differences,
they also shared some similarities. Previous studies also identified that a bias usage of AA,
such as tyrosine, alanine, aspartic acid, arginine, glycine and serine, occurred in both
human and murine VH CDR3 [31,32]. Similar AA usage of human and murine VH
CDR3 at conserved positions was observed except for murine tyrosine-rich position
117. A similar trend showing the mutation of V region was observed in both human
and mouse and demonstrated that the number of sequences decreased as the number
of AA changes increased. Moreover, a similar average number of nts added in the
P region were observed in both human and mouse.
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vertebrate groups were significantly different, which reflected different usage mechanisms
[30]. Past studies confirmed similarity between the generation mechanisms for human
and murine IG repertoire; however, their VH CDR3 AA compositions were significantly
different. In this study, our results suggest that somatic hypermutation and junction
diversity in human was significantly different from mouse, which reflected differences
in number of AA changes due to somatic hypermutation and number of nucleotide
insertion in N region. These findings may explain differences in their VH CDR3 AA
compositions. Currently, the number of IG sequences of other species contained
within the IMGT/LIGM-DB is still limited. Further sequencing for these species is
necessary to improve knowledge about the generation of IG diversity. And IMGT/
HighV-QUEST will strongly solve analysis of big data. Detection of IG repertoire has
potential for clinical application; finally, we propose that IMGT/HighV-QUEST could
be used to compare and analyze the high-throughput of large-scale sequence data
before and after clinical treatment or vaccine research.Conclusion
In summary, we compared the compositions and characteristics of human and murine
IG heavy chain V-regions from the IMGT/LIGM-DB through IMGT/HighV-QUEST.
Our findings suggested that human had a higher number of AA changes due to somatic
hypermutation and more abundant N-region addition than mouse, which might be an
important factor leading to differences between human and mouse in the AA composition
of VH CDR3. These findings are a benchmark for understanding VH repertoires and can
be used to characterize the VH repertoire during immune responses. The study will allow
standardized comparison for high throughput results obtained by IMGT/HighV-QUEST,
the reference portal for NGS repertoire.Methods
Retrieval of sequences
In December 2013, we queried human and murine sequences with Species (Homo sapiens
(human) or Mus musculus (house mouse)), Molecule type (cDNA), Configuration type
(rearranged), Functionality (productive) and Chain type (IG-Heavy) in the IMGT/LIGM-
DB beta version (Version:1.0-rc2; Database release:LIGMDB_V12). From this search, we
downloaded 10,507 human sequences and 8,362 murine sequences.IMGT/HighV-QUEST results for detailed statistical analysis
Overall sequences were entered into the IMGT/HighV-QUEST and two folders were
obtained, each of which contained 11 text files: (1) Summary; (2) IMGT-gapped-nt-
sequences; (3) Nt-sequences; (4) IMGT-gapped-AA-sequences; (5) AA-sequences; (6)
Junction; (7) V-REGION-mutation-a nd-AA-change-table; (8) V-REGION-nt-mutation-
statistics; (9) V-REGION-AA- changes-statistics; (10) V-REGION-mutation hotspots; (11)
Parameters.
In text file (1), some human and murine sequences were filtered out, including “No
results”, “Unknown functionality”, “Warnings”, and “more than 1” sequences. After these
filters, we obtain 9833 human sequences (Additional file 2: Accession number for human
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VHs) with ‘1 copy’.
For human ‘1 copy’ sequences, we further remove 27 unproductive sequences, 6
ambiguous sequences (IMGT/JunctionAnalysis gives no results for this JUNCTION),
430 ambiguous or incomplete sequences (“FR-IMGT lengths” column or “CDR-IMGT
lengths” column show “X” or “0”), and 30 ambiguous sequences (“AA JUNCTION”
column show “X”), in turn. Similarly, for murine ‘1 copy’ sequences, we remove 11
unproductive sequences, 54 ambiguous sequences (IMGT/JunctionAnalysis gives no
results for this JUNCTION), 478 ambiguous or incomplete sequences (“FR-IMGT
lengths” column or “CDR-IMGT lengths” column show “X” or “0”), and 136 ambiguous
sequences (“AA JUNCTION” column show “X”). After these filters, we obtain clearly
identified and unique productive human (n = 9340) and murine (n = 6657) in-frame
sequences for final research.IMGT/HighV-QUEST results statistical analysis
Through IMGT/HighV-QUEST, human (n = 9340) and murine (n = 6657) sequences
were analyzed. From new text files (1), (6) and (9), we widely analyzed these sequences
in Microsoft Office Excel, including germline gene usage, CDR3 length distribution and
AA composition, analysis of the number of AA changes due to somatic hypermutation,
and junctional diversity.Germline gene usage
Gene usage frequencies in all human and murine V-D-J families were directly counted
and computed in Excel (Additional file 1: Figure S1).
Analysis of the number of AA changes due to somatic hypermutation
AA changes in FR1-IMGT Nb, CDR1-IMGT Nb, FR2-IMGT Nb, CDR2-IMGT Nb and
FR3-IMGT Nb were filtered from the text file (9) of human and mouse (number of AA
changes of VH = FR1+ CDR1+ FR2+ CDR2+ FR3), and percentages of sequences of
different numbers of AA changes and number of AA changes in each region were
obtained (Figure 1A and B).
CDR3 length distribution and AA composition
In text file (1), AA JUNCTION was a CDR3 AA sequence with constant positions 104
and 108 which were deleted in analyzing the CDR3 sequences. Both human and murine
CDR3 sequences (positions 105–117) were determined by IMGT numbering [26-28],
and the CDR3 length distribution (Additional file 1: Figure S2) and frequencies of 20
different amino acids in CDR3 (Figure 2) were obtained; amino acid frequencies of all
positions of overall CDR3 AA sequences were computed (Figure 3).
Junctional diversity
P3'V-nt nb, N1-REGION-nt nb, P5'D-nt nb, N2-REGION-nt nb, P5'J-nt nb, 3'V-RE-
GION trimmed-nt nb, 5'D-REGION trimmed-nt nb, 3'D-REGION trimmed-nt nb and
5'J-REGION trimmed-nt nb were filtered from the text file (6) of human and mouse,
and number of nucleotides inserted and deleted in each region was obtained (Figure 4).
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IMGT/HighV-QUEST (version 1.2.0) was used for identification of sequences (VH,
DH, JH and CDR3), evaluation of functionality and statistical analysis of sequence data;
IMGT/V-QUEST (version 3.2.32) was used for identification of positions of CDR3;
Microsoft Office Excel (version 2010) was used for storage, filtering and statistical
calculation of sequences.
Additional files
Additional file 1: Figure S1. Gene usage frequencies observed for the VH domain of human (n = 9340) and mouse
(n = 6657) Ig sequenses published in the IMGT/LIGM-DB database. Each of the mapped and unmapped IGHV genes
usage was calculated as the percentage of the total unique population of productive and in-frame sequences according
to IMGT/HighV-QUEST Statistical Analysis Report. A-H IGHV subgroup (green bar), IGHD set (red bar), and IGHJ (yellow
bar) gene utilization observed in human and mouse sequences. Figure S2. Length distribution of VH CDR3 regions
(position 105-117) in all unique and productive human (n = 9340) and murine (n = 6657) sequences. Note that the
length of the VH CDR3 region according to the definition used by IMGT.
Additional file 2: Accession number for human IG VHs.
Additional file 3: Accession number for mouse IG VHs.
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